- MediWound (NASDAQ:MDWD) on Monday said that it has entered into a definitive share purchase agreement which includes the sale and purchase of 1.5M shares of the company’s ordinary shares with a par value NIS 0.07 in a private investment in public equity.
- The company added that the gross proceeds from the PIPE Offering are $25M.
- MediWound plans to use the net proceeds to advance EscharEx pre-commercial activities, expedite the development of large-scale manufacturing capabilities specifically for EscharEx, and support general corporate purposes.
- The company also said that the PIPE offering is expected to close within several days.
- Press release.
2024-07-15